Log In
Tuesday 25th October 2016

Chemo drug boosts child leukaemia survival

6th December 2010

The results of a Cancer Research UK study have shown that giving the drug mitoxantrone to children with leukaemia substantially increased survival rates. 

Children whose acute lymphoblastic leukaemia returned and who were given the drug showed a 69% survival rate after three years. Professor Vaskar Saha, a child cancer specialist at the Paterson Institute in Manchester, who worked on the study, said: "These striking results show just what a powerful drug mitoxantrone is in treating children whose leukaemia has returned, offering hope to many families across the country."


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2016